Open-label rusfertide

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraNCT06033586PTGXPhase 3Active not recruiting2026-04-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.